Selected research
Market Structure
Global Oncolytic Virus Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Oncolytic Virus Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Oncolytic Virus Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Oncolytic Virus Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Oncolytic Virus Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Oncolytic Virus Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Oncolytic Virus Service include Creative Biolabs, Creative Biogene, Recipharm, Nabios, IDT Biologika, FUJIFILM Diosynth Biotechnologies, Exothera, Lonza and ABL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Oncolytic Virus Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Oncolytic Virus Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Oncolytic Virus Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Oncolytic Virus Service market size, projected growth trends, production technologies, key applications, and end-use industries.
Oncolytic Virus Service Segment by Company
Creative Biolabs
Creative Biogene
Recipharm
Nabios
IDT Biologika
FUJIFILM Diosynth Biotechnologies
Exothera
Lonza
ABL
Takara Bio
Libentech
Oncolytic Virus Service Segment by Type
Measles Virus (MeV)
Herpes Simplex Virus (HSV-1)
Others
Oncolytic Virus Service Segment by Application
Tumor Treatment
Scientific Research
Oncolytic Virus Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncolytic Virus Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oncolytic Virus Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncolytic Virus Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Oncolytic Virus Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oncolytic Virus Service industry.
Chapter 3: Detailed analysis of Oncolytic Virus Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oncolytic Virus Servicerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Measles Virus (MeV)
- Herpes Simplex Virus (HSV-1)
- Others
Applications
- Tumor Treatment
- Scientific Research
Companies covered
- Creative Biolabs
- Creative Biogene
- Recipharm
- Nabios
- IDT Biologika
- FUJIFILM Diosynth Biotechnologies
- Exothera
- Lonza
- ABL
- Takara Bio
- Libentech
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Oncolytic Virus Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Measles Virus (MeV)
- 1.2.3 Herpes Simplex Virus (HSV-1)
- 1.2.4 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Oncolytic Virus Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Tumor Treatment
- 1.3.3 Scientific Research
- 1.4 Global Market Growth Prospects
- 1.5 Global Oncolytic Virus Service Growth Trends by Region
- 1.5.1 Global Oncolytic Virus Service Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Oncolytic Virus Service Market Size by Region (2021-2026)
- 1.5.3 Oncolytic Virus Service Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Oncolytic Virus Service Market Dynamics
- 2.1 Oncolytic Virus Service Industry Trends
- 2.2 Oncolytic Virus Service Industry Drivers
- 2.3 Oncolytic Virus Service Industry Opportunities and Challenges
- 2.4 Oncolytic Virus Service Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Oncolytic Virus Service Revenue by Company (2021-2026)
- 3.2 Global Oncolytic Virus Service Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Oncolytic Virus Service Key Company Head office and Area Served
- 3.4 Global Oncolytic Virus Service Company, Product Type & Application
- 3.5 Global Oncolytic Virus Service Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Oncolytic Virus Service Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Oncolytic Virus Service Players Market Share by Revenue in 2025
- 3.6.3 2025 Oncolytic Virus Service Tier 1, Tier 2, and Tier 3
4 Oncolytic Virus Service Market by Type
- 4.1 Global Oncolytic Virus Service Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Oncolytic Virus Service Market Size by Type (2021-2032)
- 4.3 Global Oncolytic Virus Service Market Size Share by Type (2021-2032)
5 Oncolytic Virus Service Market by Application
- 5.1 Global Oncolytic Virus Service Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Oncolytic Virus Service Market Size by Application (2021-2032)
- 5.3 Global Oncolytic Virus Service Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Creative Biolabs
- 6.1.1 Creative Biolabs Company Information
- 6.1.2 Creative Biolabs Business Overview
- 6.1.3 Creative Biolabs Oncolytic Virus Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Creative Biolabs Oncolytic Virus Service Product Portfolio
- 6.1.5 Creative Biolabs Recent Developments
- 6.2 Creative Biogene
- 6.2.1 Creative Biogene Company Information
- 6.2.2 Creative Biogene Business Overview
- 6.2.3 Creative Biogene Oncolytic Virus Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Creative Biogene Oncolytic Virus Service Product Portfolio
- 6.2.5 Creative Biogene Recent Developments
- 6.3 Recipharm
- 6.3.1 Recipharm Company Information
- 6.3.2 Recipharm Business Overview
- 6.3.3 Recipharm Oncolytic Virus Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Recipharm Oncolytic Virus Service Product Portfolio
- 6.3.5 Recipharm Recent Developments
- 6.4 Nabios
- 6.4.1 Nabios Company Information
- 6.4.2 Nabios Business Overview
- 6.4.3 Nabios Oncolytic Virus Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Nabios Oncolytic Virus Service Product Portfolio
- 6.4.5 Nabios Recent Developments
- 6.5 IDT Biologika
- 6.5.1 IDT Biologika Company Information
- 6.5.2 IDT Biologika Business Overview
- 6.5.3 IDT Biologika Oncolytic Virus Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 IDT Biologika Oncolytic Virus Service Product Portfolio
- 6.5.5 IDT Biologika Recent Developments
- 6.6 FUJIFILM Diosynth Biotechnologies
- 6.6.1 FUJIFILM Diosynth Biotechnologies Company Information
- 6.6.2 FUJIFILM Diosynth Biotechnologies Business Overview
- 6.6.3 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Service Product Portfolio
- 6.6.5 FUJIFILM Diosynth Biotechnologies Recent Developments
- 6.7 Exothera
- 6.7.1 Exothera Company Information
- 6.7.2 Exothera Business Overview
- 6.7.3 Exothera Oncolytic Virus Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Exothera Oncolytic Virus Service Product Portfolio
- 6.7.5 Exothera Recent Developments
- 6.8 Lonza
- 6.8.1 Lonza Company Information
- 6.8.2 Lonza Business Overview
- 6.8.3 Lonza Oncolytic Virus Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Lonza Oncolytic Virus Service Product Portfolio
- 6.8.5 Lonza Recent Developments
- 6.9 ABL
- 6.9.1 ABL Company Information
- 6.9.2 ABL Business Overview
- 6.9.3 ABL Oncolytic Virus Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 ABL Oncolytic Virus Service Product Portfolio
- 6.9.5 ABL Recent Developments
- 6.10 Takara Bio
- 6.10.1 Takara Bio Company Information
- 6.10.2 Takara Bio Business Overview
- 6.10.3 Takara Bio Oncolytic Virus Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Takara Bio Oncolytic Virus Service Product Portfolio
- 6.10.5 Takara Bio Recent Developments
- 6.11 Libentech
- 6.11.1 Libentech Company Information
- 6.11.2 Libentech Business Overview
- 6.11.3 Libentech Oncolytic Virus Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Libentech Oncolytic Virus Service Product Portfolio
- 6.11.5 Libentech Recent Developments
7 North America
- 7.1 North America Oncolytic Virus Service Market Size (2021-2032)
- 7.2 North America Oncolytic Virus Service Market Size by Type
- 7.2.1 North America Oncolytic Virus Service Market Size by Type (2021-2026)
- 7.2.2 North America Oncolytic Virus Service Market Size by Type (2027-2032)
- 7.2.3 North America Oncolytic Virus Service Market Share by Type (2021-2032)
- 7.3 North America Oncolytic Virus Service Market Size by Application
- 7.3.1 North America Oncolytic Virus Service Market Size by Application (2021-2026)
- 7.3.2 North America Oncolytic Virus Service Market Size by Application (2027-2032)
- 7.3.3 North America Oncolytic Virus Service Market Share by Application (2021-2032)
- 7.4 North America Oncolytic Virus Service Market Size by Country
- 7.4.1 North America Oncolytic Virus Service Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Oncolytic Virus Service Market Size by Country (2021-2026)
- 7.4.3 North America Oncolytic Virus Service Market Size by Country (2027-2032)
- 7.4.4 North America Oncolytic Virus Service Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Oncolytic Virus Service Market Size (2021-2032)
- 8.2 Europe Oncolytic Virus Service Market Size by Type
- 8.2.1 Europe Oncolytic Virus Service Market Size by Type (2021-2026)
- 8.2.2 Europe Oncolytic Virus Service Market Size by Type (2027-2032)
- 8.2.3 Europe Oncolytic Virus Service Market Share by Type (2021-2032)
- 8.3 Europe Oncolytic Virus Service Market Size by Application
- 8.3.1 Europe Oncolytic Virus Service Market Size by Application (2021-2026)
- 8.3.2 Europe Oncolytic Virus Service Market Size by Application (2027-2032)
- 8.3.3 Europe Oncolytic Virus Service Market Share by Application (2021-2032)
- 8.4 Europe Oncolytic Virus Service Market Size by Country
- 8.4.1 Europe Oncolytic Virus Service Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Oncolytic Virus Service Market Size by Country (2021-2026)
- 8.4.3 Europe Oncolytic Virus Service Market Size by Country (2027-2032)
- 8.4.4 Europe Oncolytic Virus Service Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Oncolytic Virus Service Market Size (2021-2032)
- 9.2 China Oncolytic Virus Service Market Size by Type
- 9.2.1 China Oncolytic Virus Service Market Size by Type (2021-2026)
- 9.2.2 China Oncolytic Virus Service Market Size by Type (2027-2032)
- 9.2.3 China Oncolytic Virus Service Market Share by Type (2021-2032)
- 9.3 China Oncolytic Virus Service Market Size by Application
- 9.3.1 China Oncolytic Virus Service Market Size by Application (2021-2026)
- 9.3.2 China Oncolytic Virus Service Market Size by Application (2027-2032)
- 9.3.3 China Oncolytic Virus Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Oncolytic Virus Service Market Size (2021-2032)
- 10.2 Asia Oncolytic Virus Service Market Size by Type
- 10.2.1 Asia Oncolytic Virus Service Market Size by Type (2021-2026)
- 10.2.2 Asia Oncolytic Virus Service Market Size by Type (2027-2032)
- 10.2.3 Asia Oncolytic Virus Service Market Share by Type (2021-2032)
- 10.3 Asia Oncolytic Virus Service Market Size by Application
- 10.3.1 Asia Oncolytic Virus Service Market Size by Application (2021-2026)
- 10.3.2 Asia Oncolytic Virus Service Market Size by Application (2027-2032)
- 10.3.3 Asia Oncolytic Virus Service Market Share by Application (2021-2032)
- 10.4 Asia Oncolytic Virus Service Market Size by Country
- 10.4.1 Asia Oncolytic Virus Service Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Oncolytic Virus Service Market Size by Country (2021-2026)
- 10.4.3 Asia Oncolytic Virus Service Market Size by Country (2027-2032)
- 10.4.4 Asia Oncolytic Virus Service Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Oncolytic Virus Service Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Oncolytic Virus Service Market Size by Type
- 11.2.1 South America, Middle East & Africa Oncolytic Virus Service Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Oncolytic Virus Service Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Oncolytic Virus Service Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Oncolytic Virus Service Market Size by Application
- 11.3.1 South America, Middle East & Africa Oncolytic Virus Service Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Oncolytic Virus Service Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Oncolytic Virus Service Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Oncolytic Virus Service Market Size by Country
- 11.4.1 South America, Middle East & Africa Oncolytic Virus Service Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Oncolytic Virus Service Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Oncolytic Virus Service Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Oncolytic Virus Service Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst